文献速递脊柱关节炎

正确诊断中轴型脊柱关节炎对患者与社会的价值

The value of correctly diagnosing axial spondyloarthritis for patients and society.
PubMed 文献 · Semin Arthritis Rheum · 2023-07-05

该研究基于SPACE等队列数据构建决策树与状态转换模型,在60年时间跨度内比较三种中轴型脊柱关节炎诊断算法与完美诊断的健康(QALYs)与成本。结果显示,每正确诊断一名患者可多获得至多4.7个QALYs并节省至多6万欧元;不强制要求炎性背痛作为准入标准的M2算法健康获益更多、成本更低,完美诊断每人可花费7500欧元仍具足够价值。

要点

  • 每正确诊断一名中轴型脊柱关节炎患者,最多可多获得4.7个QALYs并节省6万欧元。
  • M2算法(不强制炎性背痛为准入标准)每人24.23个QALYs、157469欧元,优于BER与M1。
  • 完美诊断每人可花费7500欧元仍提供足够价值。

核心结论

  • 正确诊断中轴型脊柱关节炎可为患者和社会带来显著的健康与成本获益。
  • 不强制要求炎性背痛作为诊断准入标准的M2算法提供更多价值,更可取。
  • 比M2准确性更高但费用高得多的诊断算法仍可被认为具有良好成本效益。

研究设计与样本

  • 利用SPACE等队列数据构建模型,结合决策树(诊断)与状态转换模型(治疗)。
  • 在因下背痛转诊至风湿科的患者中,比较三种中轴型脊柱关节炎诊断算法,时间跨度为60年。
  • 三种算法为柏林算法(BER,特异性最高)、修改1(M1,炎性背痛标准较宽松)和修改2(M2,炎性背痛不作为强制准入标准,敏感性最高)。
  • 探索了敏感性/特异性的变化,并评估了完美诊断的价值。

主要发现

  • 从社会视角看,每正确诊断一名中轴型脊柱关节炎患者,最多可多获得4.7个QALYs并节省6万欧元。
  • M2算法每人24.23个QALYs、157469欧元,BER算法每人23.96个QALYs、159423欧元,M1算法每人24.15个QALYs、158417欧元。
  • M2算法较BER和M1带来更多健康并降低每人成本。
  • 假设性提高M2敏感性比提高特异性带来略多的价值。
  • 完美诊断每人可花费7500欧元仍提供足够价值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To demonstrate the value of diagnosing axSpA, by comparing health and costs associated with available diagnostic algorithms and perfect diagnosis. METHODS: Using data from SPACE and other cohorts, a model was developed to estimate health (quality-adjusted life-years, QALYs) and costs (healthcare consumption and work productivity losses) of different diagnostic algorithms for axSpA amongst patients with low back pain referred to a rheumatologist, over a 60-year horizon. The model combined a decision-tree (diagnosis) with a state-transition model (treatment). The three algorithms (Berlin [BER, highest specificity], Modification 1 [M1; less strict inflammatory back pain (IBP) criterion] and Modification 2 [M2; IBP not mandatory as entry criterion, highest sensitivity]) were compared. Changes in sensitivity/specificity were explored and the value of perfect diagnosis was investigated. RESULTS: For each correctly diagnosed axSpA patient, up to 4.7 QALYs and €60,000 could be gained/saved, considering a societal perspective. Algorithm M2 resulted in more health and lower costs per patient (24.23 QALYs; €157,469), compared to BER (23.96 QALYs; €159,423) and M1 (24.15 QALYs; €158,417). Hypothetical improvements in M2 sensitivity resulted in slightly more value compared to improvements in specificity. Perfect diagnosis can cost €7,500 per patient and still provide enough value. CONCLUSION: Correct diagnosis of axSpA results in substantial health and cost benefits for patients and society. Not requiring IBP as mandatory for diagnosis of axSpA (algorithm M2) provides more value and would be preferable. A considerably more expensive diagnostic algorithm with better accuracy than M2 would still be considered good value for money.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Webers C, Grimm S, van Tubergen A, et al. The value of correctly diagnosing axial spondyloarthritis for patients and society. Semin Arthritis Rheum. 2023. PMID: 37451047. doi:10.1016/j.semarthrit.2023.152242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。